Herbal Drug BNO 1016 Versus Fluticasone Propionate Nasal Spray in the Treatment of Chronic Rhinosinusitis without Nasal Polyps: A Preliminary Report

Abstract

Objective: Current evidence supports the use of herbal drugs in the reduction of symptoms of acute (ARS) and chronic rhinosinusitis (CRS). Intranasal corticosteroids are the first line treatment option for treating CRS with or without nasal polyps. This studywas designed to compare the safety and efficacy of plant medication BNO 1016 and fluticasone propionate nasal spray (FPNS) fortreating CRS without nasal polyps (CRSsNP).Methods: Forty subjects with CRSsNP were randomly divided into two treatment groups that comprised 20 patients each. Thepatients from Group 1 were treated with herbal drug BNO 1016, tablets of 160 mg, 3×1/d per os, for 28 d. The patients from Group2 used FPNS 200 μg once daily, 2 puffs in each nostril in the morning for 28 d. We evaluated the nasal total symptom score (TSS),individual scores for each symptom (nasal congestion/obstruction, rhinorrhea/postnasal discharge, facial pain with the sense ofpressure, headache, loss of the sense of smell), total endoscopic score (TES), and individual endoscopic signs (edema of the nasalmucosa, nasal secretion, and nasal crusting), before and after the therapy.Results: TSS was lower on Day 7 (p=0.008), Day 14 (p=0.004), Day 21 (p